Monitoring the Evolution of Portal Hypertension After Sustained Virologic Response

Gastroenterology. 2018 Apr;154(5):1550-1551. doi: 10.1053/j.gastro.2017.08.078. Epub 2018 Mar 8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antiviral Agents
  • Drug Therapy, Combination
  • Hepatitis C, Chronic
  • Humans
  • Hypertension, Portal
  • Interferon-alpha
  • Recombinant Proteins
  • Ribavirin*
  • Sustained Virologic Response*
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Recombinant Proteins
  • Ribavirin